A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy
Conclusion:
This is the first case report on the ineffectiveness of triple immunosuppressant combination therapy recommended by the guidelines for immune-related hepatotoxicity. It is necessary to develop more appropriate treatment for severe sclerosing cholangitis-like irAE based on the robust evidence.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
More News: Bile | Bilirubin | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Endocrinology | Hepatitis | Hepatocellular Carcinoma | Internal Medicine | Liver | Liver Cancer | Pain | Pain Management | Prednisolone | Prograf | Squamous Cell Carcinoma | Study | Tacrolimus | Urology & Nephrology